Overview

Immune subsets: High resolution

Admixes: Studying a complex network

NCIP™: Novel Clinical Indication Profiling

 

 

 

 

 

 

 

 

 

 

Celentyx’s unique Immuno-Profiling™ platform technology allows rapid analysis of drug or biopharmaceutical action on human immune cells (normal resting or activated, or pathological).

 

Celentyx allows access to it's powerful Immuno-Profiling™ platform through it's Immuno-Profiling™ services.